144 ·Filed Jun 5, 2026

ANAB

ANAPTYSBIO, INC
BEARISH
Impact 5/10
Horizondays Processed3mo ago SEC0001950047-26-005723
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

The sustained selling by an officer over multiple weeks is a bearish signal, especially given the historical underperformance of prior bullish calls on ANAB (T+20 win rate 33%). Monitor for additional Form 4 filings and any upcoming corporate events (earnings, pipeline updates) that could explain the selling. The stock's high analyst bullishness (94% buy ratings) contrasts with insider behavior, creating a potential divergence to watch.

DirectionBearish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
ANAB ▲ +7.63% at T+60d
SHORT call ✗ call lost -7.63% · α vs SPY -4.58% · entry $51.36 → $55.28
Entry anchored
Jun 5, 2026
via day open
T+1d
+0.53%
call -0.53% · α -0.82%
$51.63
settled 4mo ago
T+5d
+15.87%
call -15.87% · α -13.76%
$59.51
settled 4mo ago
T+20d
+21.32%
call -21.32% · α -19.69%
$62.31
settled 3mo ago
T+60d
+7.63%
call -7.63% · α -4.58%
$55.28
settled 4w ago

Price Chart

Loading chart...

Executive Summary

Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 on June 5, 2026, indicating intent to sell 22,491 shares of common stock valued at approximately $1.15 million. The filing also reveals a pattern of recent sales totaling over 160,000 shares in the prior two weeks, suggesting a sustained insider selling campaign rather than a one-off liquidity event.

Key Facts

  • Officer Dennis Mulroy filed Form 144 to sell 22,491 shares valued at ~$1.15 million.
  • The filing also discloses 13 prior sales between May 15 and June 4, 2026, totaling ~160,422 shares for ~$8.7 million.
  • The proposed sale is attributed to a stock option exercise, but the aggregate selling pattern is substantial.
  • Market cap is ~$1.5B, so the total disclosed sales (~$9.9M) represent ~0.66% of market cap.
  • No other insider activity reported in the last 30 days per market data snapshot.

Financial Impact

Total disclosed insider sales of ~$9.9 million over the past three weeks, with the latest 144 adding ~$1.15 million.

insider selling volumedilution from option exercise

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed, but the pattern of recent completed sales is confirmed.
  • The selling could be for personal diversification or tax planning, not necessarily a reflection of company outlook.
  • High analyst consensus may already be priced in, and insider selling could precede negative news.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005723
Document: 0001950047-26-005723-index.html0001950047-26-005723
Document: 0001950047-26-005723.txt0001950047-26-005723
24 reports for ANAB
Performance horizon
71% Hit rate 12 of 17 directional calls best @ T+60▲ +41.26%Mar 3, 2026
Filters
Rows
Reports for ANAB — sortable, filterable
TypeNow
Aug 12, 2026
7w ago
Institutional Cluster
BULLISH ★ 5/10
$56.02 $53.87▼ −3.84%▼ −2.09%$48.53 (−13.37%)
Jun 29, 2026
13w ago
144
BEARISH ★ 6/10
$67.50 $53.61▲ +20.58%▲ +19.55%$48.53 (+28.10%)
Jun 29, 2026
13w ago
DEFA14A
NEUTRAL ★ 2/10
$67.50 $53.61▼ −20.58%▼ −19.55%$48.53 (−28.10%)
Jun 26, 2026
13w ago
144
BEARISH ★ 6/10
$65.97 $54.15▲ +17.92%▲ +17.64%$48.53 (+26.44%)
Jun 22, 2026
14w ago
8-K
NEUTRAL ★ 2/10
$59.43 $50.29▼ −15.38%▼ −16.54%$48.53 (−18.34%)
Jun 17, 2026
15w ago
144
BEARISH ★ 5/10
$57.51 $54.15▲ +5.84%▲ +6.38%$48.53 (+15.61%)
Jun 15, 2026
15w ago
144
BEARISH ★ 6/10
$57.61 $62.51▼ −8.51%▼ −8.31%$48.53 (+15.76%)
Jun 11, 2026
16w ago
144
BEARISH ★ 6/10
$56.07 $66.39▼ −18.41%▼ −16.63%$48.53 (+13.45%)
Jun 10, 2026
16w ago
144
BEARISH ★ 5/10
$54.24 $66.59▼ −22.77%▼ −20.88%$48.53 (+10.53%)
Jun 8, 2026
16w ago
144
BEARISH ★ 5/10
$51.63 $67.33▼ −30.40%▼ −28.95%$48.53 (+6.00%)
Showing 10 of 24

US Market Status

Market Closed — Opens Mon (65h)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access